CLINICAL_TRIALS
trial_result
· 2016-08-02
Clinical Trial Update: Phase I Trial of DAR-901 [Phase 1]
Summary
The Phase I trial of DAR-901 for tuberculosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED